LV10195B - Composition for stabilizing blood plasma during pasteurization and pasteurized plasma solution for therapeutic use - Google Patents

Composition for stabilizing blood plasma during pasteurization and pasteurized plasma solution for therapeutic use Download PDF

Info

Publication number
LV10195B
LV10195B LVP-93-113A LV930113A LV10195B LV 10195 B LV10195 B LV 10195B LV 930113 A LV930113 A LV 930113A LV 10195 B LV10195 B LV 10195B
Authority
LV
Latvia
Prior art keywords
plasma
composition
composition according
concentration
lysine
Prior art date
Application number
LVP-93-113A
Other languages
English (en)
Latvian (lv)
Other versions
LV10195A (lv
Inventor
Miryana Nee Radosevich Burnouf
Original Assignee
Aetsrn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aetsrn filed Critical Aetsrn
Publication of LV10195A publication Critical patent/LV10195A/xx
Publication of LV10195B publication Critical patent/LV10195B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
LVP-93-113A 1992-02-13 1993-02-10 Composition for stabilizing blood plasma during pasteurization and pasteurized plasma solution for therapeutic use LV10195B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9201604A FR2687317B1 (fr) 1992-02-13 1992-02-13 Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.

Publications (2)

Publication Number Publication Date
LV10195A LV10195A (lv) 1994-10-20
LV10195B true LV10195B (en) 1995-04-20

Family

ID=9426597

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-113A LV10195B (en) 1992-02-13 1993-02-10 Composition for stabilizing blood plasma during pasteurization and pasteurized plasma solution for therapeutic use

Country Status (20)

Country Link
EP (1) EP0556096B1 (de)
JP (2) JP4010573B2 (de)
AT (1) ATE171074T1 (de)
BR (1) BR9300524A (de)
CA (1) CA2089446C (de)
CZ (1) CZ285573B6 (de)
DE (1) DE69321007T2 (de)
DK (1) DK0556096T3 (de)
EE (1) EE03091B1 (de)
ES (1) ES2121065T3 (de)
FI (1) FI103380B1 (de)
FR (1) FR2687317B1 (de)
HU (1) HU210026B (de)
LT (1) LT3226B (de)
LV (1) LV10195B (de)
NO (1) NO306532B1 (de)
PL (1) PL174098B1 (de)
RU (1) RU2112522C1 (de)
SK (1) SK280665B6 (de)
UA (1) UA27102C2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501189D0 (sv) * 1995-03-31 1995-03-31 Pharmacia Ab Protein formulation
US5616159A (en) * 1995-04-14 1997-04-01 Corning Incorporated Method of forming high purity fused silica having high resistance to optical damage
US6619073B2 (en) 1996-03-05 2003-09-16 Corning Incorporated Method of increasing the initial transmittance of optical glass
US5827640A (en) * 1996-06-14 1998-10-27 Biostore New Zealand Limited Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose
US5879875A (en) * 1996-06-14 1999-03-09 Biostore New Zealand Compositions and methods for the preservation of living tissues
US5962213A (en) * 1996-06-14 1999-10-05 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
WO1997047192A1 (en) * 1996-06-14 1997-12-18 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
US6361933B1 (en) 1996-06-14 2002-03-26 Biostore New Zealand Limited Solutions for the preservation of tissues
US6037116A (en) * 1996-06-14 2000-03-14 Biostore New Zealand, Ltd. Compositions comprising betaine, sodium citrate and sodium chloride and methods for the preservation of biological materials
US6114107A (en) * 1996-06-14 2000-09-05 Biostore New Zealand Limited Composition comprising raffinose, TMAO, sodium citrate and methods for the preservation of living tissues
RU2174841C1 (ru) * 2000-06-06 2001-10-20 Российский научно-исследовательский институт гематологии и трансфузиологии Способ получения пула нормальной плазмы
US6915665B2 (en) 2000-10-31 2005-07-12 Corning Incorporated Method of inducing transmission in optical lithography preforms
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
ES2264403B1 (es) * 2006-06-22 2007-11-01 Grifols S.A. Medio de suspension de hematies.
DE102011056142A1 (de) * 2011-12-07 2013-06-13 Manfred Rüdinger Metabolisierbare Salze und deren Verwendung in Diagnostik und Therapie
RU2639446C1 (ru) * 2016-11-23 2017-12-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ярославский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ хранения плазмы крови, содержащей лекарственные вещества с нестабильными фенольными гидроксилами

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第８因子の加熱処理法
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
FR2650508A1 (fr) * 1989-08-01 1991-02-08 Fondation Nale Transfusion San Colle pasteurisee pour reunir des tissus humain ou animal
FR2664165B1 (fr) 1990-07-03 1992-10-16 Lille Transfusion Sanguine Composition pour stabiliser le plasma sanguin en cours de pasteurisation.

Also Published As

Publication number Publication date
NO306532B1 (no) 1999-11-22
FI103380B (fi) 1999-06-30
LV10195A (lv) 1994-10-20
CA2089446C (fr) 2006-04-18
EP0556096B1 (de) 1998-09-16
NO930473L (no) 1993-08-16
UA27102C2 (uk) 2000-02-28
PL297699A1 (en) 1994-01-10
CA2089446A1 (fr) 1993-08-14
SK280665B6 (sk) 2000-05-16
DK0556096T3 (da) 1999-06-14
FI930630A0 (fi) 1993-02-12
LTIP338A (en) 1994-08-25
ATE171074T1 (de) 1998-10-15
FR2687317A1 (fr) 1993-08-20
NO930473D0 (no) 1993-02-11
BR9300524A (pt) 1993-09-28
LT3226B (en) 1995-04-25
JPH0624997A (ja) 1994-02-01
ES2121065T3 (es) 1998-11-16
EP0556096A1 (de) 1993-08-18
HUT63768A (en) 1993-10-28
CZ285573B6 (cs) 1999-09-15
FI930630L (fi) 1993-08-14
SK8293A3 (en) 1993-10-06
JP4472672B2 (ja) 2010-06-02
PL174098B1 (pl) 1998-06-30
FI103380B1 (fi) 1999-06-30
JP2006306892A (ja) 2006-11-09
RU2112522C1 (ru) 1998-06-10
JP4010573B2 (ja) 2007-11-21
DE69321007T2 (de) 1999-04-01
HU9300377D0 (en) 1993-04-28
HU210026B (en) 1995-01-30
EE03091B1 (et) 1998-06-15
FR2687317B1 (fr) 1995-06-23
CZ16193A3 (en) 1993-12-15
DE69321007D1 (de) 1998-10-22

Similar Documents

Publication Publication Date Title
DE3400413C2 (de)
DK156698B (da) Fremgangsmaade til pasteurisering af et materiale indeholdende et termisk foelsomt, terapeutisk aktivtprotein valgt blandt alfa-l-antitrypsin, antithrombin-iii, praekallikrein, antihaemofil faktor (faktorviii) og fibronectin
US4876241A (en) Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
LV10195B (en) Composition for stabilizing blood plasma during pasteurization and pasteurized plasma solution for therapeutic use
JP3133338B2 (ja) ウイルス的に安全な生物学的組成物の調製方法
US4562072A (en) Process for the pasteurization of antihemophilic cryoprecipitate (AHC) and antihemophilic cryoprecipitate prepared thereby
US4379085A (en) Heat stabilization of plasma proteins
AU622102B2 (en) A pharmaceutical containing tissue protein pp4, a process for the preparation of pp4 and for the pasteurization thereof, and the use of pp4
EP0292003B1 (de) Stabilisierung von biologischen und pharmazeutischen Produkten während der Inaktivierung von viralen und bakteriellen Keimen
EP2695620B1 (de) Caprylatvirus-Deaktivierung
FI96918C (fi) Koostumus veriplasman stabiloimiseksi pastöroinnin aikana
JP2001000179A (ja) ウィルスの不活化方法
AU608832B2 (en) Method of preparing highly purified alpha-1-proteinase inhibitor
JPH0530812B2 (de)
HK1194679B (en) Caprylate viral deactivation
JPS58205495A (ja) 胎盤性アスパラギン酸アミノペプチダ−ゼの加熱安定化法